Covered recipient · General Payments record
CRYSTAL JANANI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Clinical Neurophysiology
General Payments · PY2018–2024
$2,305.53
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $535.84 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $132.54 | 8 |
| PFIZER INC. | $103.79 | 3 |
| EISAI INC. | $103.32 | 1 |
| SK Life Science, Inc. | $101.99 | 3 |
| Sumitomo Pharma America, Inc. | $26.67 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $23.41 | 1 |
| Neurelis, Inc. | $22.27 | 1 |
| Aucta Pharmaceuticals, Inc. | $21.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.46 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103986654 | CMS |
| ABBVIE INC. | $27.63 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103986656 | CMS |
| ABBVIE INC. | $2.38 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103986658 | CMS |
| ABBVIE INC. | $15.98 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103986660 | CMS |
| ABBVIE INC. | $15.21 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103986662 | CMS |
| ABBVIE INC. | $27.03 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103986664 | CMS |
| ABBVIE INC. | $13.02 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103986666 | CMS |
| ABBVIE INC. | $18.83 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103986668 | CMS |
| Aucta Pharmaceuticals, Inc. | $21.85 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147906702 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $23.41 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144444974 | CMS |
| Eisai Inc. | $103.32 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110737847 | CMS |
| Neurelis, Inc. | $22.27 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145644128 | CMS |
| PFIZER INC. | $35.01 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131113767 | CMS |
| PFIZER INC. | $38.86 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132086844 | CMS |
| PFIZER INC. | $29.92 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131191262 | CMS |
| SK Life Science, Inc. | $34.76 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154137300 | CMS |
| SK Life Science, Inc. | $35.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154137328 | CMS |
| SK Life Science, Inc. | $32.23 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154137346 | CMS |
| Sumitomo Pharma America, Inc. | $26.67 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148868827 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.